HEADER LIGASE/PEPTIDE 27-OCT-15 2N8T TITLE SOLUTION STRUCTURE OF THE RNEDD4 WW2 DOMAIN-CX43CT PEPTIDE COMPLEX BY TITLE 2 NMR COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE NEDD4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: WW2 DOMAIN; COMPND 5 EC: 6.3.2.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CX43CT PEPTIDE; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: CONNEXIN-43, CX43, GAP JUNCTION 43 KDA HEART PROTEIN; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: BROWN RAT,RAT,RATS; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: NEDD4, NEDD4A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PGEX-KT; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: CHEMICALLY SYNTHESIZED, PURCHASED FROM A VENDOR KEYWDS RNEDD4 WW2, CX43CT, PHOSPHORYLATION, LIGASE, LIGASE-PEPTIDE COMPLEX EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR G.SPAGNOL,F.KIEKEN,P.L.SORGEN REVDAT 2 22-MAR-17 2N8T 1 JRNL REVDAT 1 24-FEB-16 2N8T 0 JRNL AUTH G.SPAGNOL,F.KIEKEN,J.L.KOPANIC,H.LI,S.ZACH,K.L.STAUCH, JRNL AUTH 2 R.GROSELY,P.L.SORGEN JRNL TITL STRUCTURAL STUDIES OF THE NEDD4 WW DOMAINS AND THEIR JRNL TITL 2 SELECTIVITY FOR THE CONNEXIN43 (CX43) CARBOXYL TERMINUS. JRNL REF J. BIOL. CHEM. V. 291 7637 2016 JRNL REFN ESSN 1083-351X JRNL PMID 26841867 JRNL DOI 10.1074/JBC.M115.701417 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 1.1 REMARK 3 AUTHORS : DR. MICHAEL NILGES, INSTITUT PASTEUR REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2N8T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000104566. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 25 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 156 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.6 MM [U-98% 13C; U-98% 15N] REMARK 210 RNEDD4 WW2, 13 MM CX43CT PEPTIDE, REMARK 210 1.8 MM POTASSIUM PHOSPHATE, 1 REMARK 210 MM DTT, 137 MM SODIUM CHLORIDE, REMARK 210 2.7 MM POTASSIUM CHLORIDE, 10 MM REMARK 210 SODIUM PHOSPHATE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 3D HNHA; 3D HNCACB; REMARK 210 3D CBCA(CO)NH; 3D 1H-15N NOESY; REMARK 210 3D 1H-13C NOESY ALIPHATIC; 3D 1H- REMARK 210 13C NOESY AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA 1.1, NMRPIPE, NMRVIEW, REMARK 210 NMRDRAW REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 4 TYR A 21 CE1 TYR A 21 CZ 0.129 REMARK 500 4 TYR A 21 CZ TYR A 21 CE2 -0.129 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 2 82.01 -174.23 REMARK 500 1 SER A 3 -164.96 63.64 REMARK 500 1 PRO A 8 106.01 -56.50 REMARK 500 1 LYS A 28 77.32 75.10 REMARK 500 1 LEU B 52 -82.71 67.13 REMARK 500 2 SER A 2 -175.74 66.59 REMARK 500 2 SER A 4 -64.83 -122.84 REMARK 500 2 LYS A 28 76.57 68.62 REMARK 500 2 MET A 37 -162.74 65.56 REMARK 500 2 LEU B 42 -98.77 63.41 REMARK 500 2 SEP B 43 173.25 62.51 REMARK 500 2 SEP B 46 -66.11 -99.81 REMARK 500 2 PRO B 48 -149.97 -74.79 REMARK 500 3 SER A 4 109.59 69.37 REMARK 500 3 THR A 36 145.78 75.16 REMARK 500 3 MET A 37 -168.85 75.43 REMARK 500 3 PRO B 41 -84.52 -82.83 REMARK 500 3 PRO B 48 41.24 -79.60 REMARK 500 3 TYR B 50 -56.79 74.06 REMARK 500 4 THR A 36 95.57 -61.97 REMARK 500 4 GLN A 38 74.87 -105.16 REMARK 500 4 LEU B 42 -69.19 -129.24 REMARK 500 4 SEP B 43 172.93 62.73 REMARK 500 4 TYR B 50 -46.70 74.38 REMARK 500 5 SER A 3 -171.80 61.20 REMARK 500 5 SEP B 46 -67.07 -122.14 REMARK 500 6 SER A 4 15.76 -141.46 REMARK 500 6 LYS A 28 71.93 58.10 REMARK 500 6 LEU B 42 -20.02 77.87 REMARK 500 6 PRO B 44 -75.98 -77.72 REMARK 500 6 PRO B 47 157.04 -42.68 REMARK 500 6 PRO B 48 -51.21 -29.80 REMARK 500 6 TYR B 50 -44.97 -169.57 REMARK 500 7 SER A 3 -164.53 67.09 REMARK 500 7 LYS A 28 18.62 58.00 REMARK 500 7 MET A 37 178.57 68.20 REMARK 500 7 LEU B 52 130.84 80.59 REMARK 500 8 SER A 3 146.54 60.88 REMARK 500 8 LYS A 13 -169.29 -163.75 REMARK 500 8 TYR A 21 -169.92 -123.53 REMARK 500 8 LYS A 34 132.33 -34.25 REMARK 500 8 PRO B 41 87.00 -65.42 REMARK 500 8 LEU B 42 -33.32 175.45 REMARK 500 8 MET B 45 -78.31 -103.83 REMARK 500 8 SEP B 46 -58.92 -143.30 REMARK 500 8 PRO B 48 -166.92 -78.92 REMARK 500 9 SER A 2 -93.06 60.17 REMARK 500 9 LYS A 28 32.34 78.66 REMARK 500 9 LEU B 42 91.68 58.48 REMARK 500 9 PRO B 44 124.29 -32.07 REMARK 500 REMARK 500 THIS ENTRY HAS 61 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25865 RELATED DB: BMRB REMARK 900 RELATED ID: 2N8S RELATED DB: PDB REMARK 900 RELATED ID: 2N8U RELATED DB: PDB DBREF 2N8T A 3 39 UNP Q62940 NEDD4_RAT 400 436 DBREF 2N8T B 40 53 UNP P08050 CXA1_RAT 276 289 SEQADV 2N8T GLY A 1 UNP Q62940 EXPRESSION TAG SEQADV 2N8T SER A 2 UNP Q62940 EXPRESSION TAG SEQRES 1 A 39 GLY SER SER SER GLY LEU PRO PRO GLY TRP GLU GLU LYS SEQRES 2 A 39 GLN ASP ASP ARG GLY ARG SER TYR TYR VAL ASP HIS ASN SEQRES 3 A 39 SER LYS THR THR THR TRP SER LYS PRO THR MET GLN ASP SEQRES 1 B 14 ALA PRO LEU SEP PRO MET SEP PRO PRO GLY TYR LYS LEU SEQRES 2 B 14 VAL MODRES 2N8T SEP B 43 SER PHOSPHOSERINE MODRES 2N8T SEP B 46 SER PHOSPHOSERINE HET SEP B 43 14 HET SEP B 46 14 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP 2(C3 H8 N O6 P) SHEET 1 A 3 TRP A 10 GLN A 14 0 SHEET 2 A 3 SER A 20 ASP A 24 -1 O TYR A 21 N LYS A 13 SHEET 3 A 3 THR A 29 THR A 30 -1 O THR A 29 N ASP A 24 LINK C LEU B 42 N SEP B 43 1555 1555 1.33 LINK C SEP B 43 N PRO B 44 1555 1555 1.35 LINK C MET B 45 N SEP B 46 1555 1555 1.32 LINK C SEP B 46 N PRO B 47 1555 1555 1.35 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1